Evidence map›Paper›PMID 39921820›Full record

ReviewTissue engineering and regenerative medicine2025

Innovations in Vascular Repair from Mechanical Intervention to Regenerative Therapies.

Hye-Min Park, Chae-Lin Kim, Dasom Kong, Seon-Hee Heo, Hyun-Ji Park

Abstract readReview
In one paragraph

Review in Tissue engineering and regenerative medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Cell-Cell or Cell-Biomaterial Interactions for Therapeutic Application.Tissue engineering and regenerative medicine · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Hye-Min ParkDepartment of Molecular Science and Technology, Ajou University, Suwon, 16499, Republic of Korea.
Chae-Lin KimDepartment of Molecular Science and Technology, Ajou University, Suwon, 16499, Republic of Korea.
Dasom KongDepartment of Molecular Science and Technology, Ajou University, Suwon, 16499, Republic of Korea.
Seon-Hee HeoDepartment of Surgery, Yonsei University College of Medicine, Seoul, 03722, Republic of Korea. SUNNYMS@yuhs.ac.
Hyun-Ji ParkDepartment of Molecular Science and Technology, Ajou University, Suwon, 16499, Republic of Korea. hyunjipark@ajou.ac.kr.

Funding

Ministry of Trade, Industry and Energy KEIT 20018560Ministry of Trade, Industry and Energy NTIS 2410005252the National Research Foundation of Korea (KR) RS-2023-00245238through the National Research Foundation of Korea RS-2024-00411474
6 · The paper itself

Abstract

backgroundVascular diseases, including atherosclerosis and thrombosis, are leading causes of morbidity and mortality worldwide, often resulting in vessel stenosis that impairs blood flow and leads to severe clinical outcomes. Traditional mechanical interventions, such as balloon angioplasty and bare-metal stents, provided initial solutions but were limited by restenosis and thrombosis. The advent of drug-eluting stents improved short-term outcomes by inhibiting vascular smooth muscle cell proliferation, however, they faced challenges including delayed reendothelialization and late-stage thrombosis.

methodsThis review highlights the progression from mechanical to biological interventions in treating vascular stenosis and underscores the need for integrated approaches that combine mechanical precision with regenerative therapies.

resultsTo address long-term complications, bioresorbable stents were developed to provide temporary scaffolding that gradually dissolves, yet they still encounter challenges with mechanical integrity and optimal degradation rates. Consequently, emerging therapies now focus on biological approaches, such as gene therapy, extracellular vesicle treatments, and cell therapies, that aim to promote vascular repair at the cellular level. These strategies offer the potential for true vascular regeneration by enhancing endothelialization, modulating immune responses, and stimulating angiogenesis.

conclusionIntegrating mechanical precision with regenerative biological therapies offers a promising future for treating vascular stenosis. A comprehensive approach combining these modalities could achieve sustainable vascular health.

Indexed as

RegenerationRegenerative MedicineVascular DiseasesAnimalsHumansRegenerative therapiesStent technologiesVascular repair

Identifiers

PMID39921820
PMCPMC12122965

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.